Company Filing History:
Years Active: 1997
Title: Ren E Imwinkelried: Innovator in Pharmaceutical Chemistry
Introduction
Ren E Imwinkelried is a notable inventor based in Brig-Glis, Switzerland. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of antiviral compounds and antihypertensive agents. With a total of 2 patents, her work has had a meaningful impact on medical research and drug development.
Latest Patents
Imwinkelried's latest patents include innovative compounds such as carbocyclic nucleosides containing bicyclic rings and oligonucleotides. These compounds can serve as antiviral active ingredients or be utilized in the preparation of biologically active oligonucleotides. Additionally, she has developed a process for producing 2-substituted 5-chlorimidazoles, which are new intermediate products for creating antihypertensive pharmaceutical agents or herbicidal compounds.
Career Highlights
Throughout her career, Ren E Imwinkelried has worked with prominent companies in the pharmaceutical industry, including Ciba-Geigy Corporation and Lonza Inc. Her expertise in the field has allowed her to contribute to various innovative projects and advancements in drug development.
Collaborations
Imwinkelried has collaborated with esteemed colleagues such as Karl-Heinz Altmann and Albert Eschenmoser. These partnerships have further enriched her research and development efforts in pharmaceutical chemistry.
Conclusion
Ren E Imwinkelried's contributions to the field of pharmaceutical chemistry exemplify her dedication to innovation and research. Her patents and collaborations highlight her role as a significant figure in the development of new medical compounds.